Choosing drugs for secondary prevention after myocardial infarction: a pragmatic approach
Open Access
- 1 June 1995
- journal article
- research article
- Published by Oxford University Press (OUP)
- Vol. 71 (836), 321-322
- https://doi.org/10.1136/pgmj.71.836.321
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators.Heart, 1994
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Cumulative Meta-Analysis of Therapeutic Trials for Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTIONThe Lancet, 1988
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981